The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells

Altered Fibroblast Growth Factor Receptor 4 Stability Promotes Prostate Cancer Progression

(2015) Jianghua Wang et al.   NEOPLASIA

Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation

(2009) A. Roidl et al.   CLINICAL CANCER RESEARCH

The Y606CRETmutation causes a receptor gain of function

(2008) T. Ercolino et al.   CLINICAL ENDOCRINOLOGY

Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population

(2008) Zhiyong Ma et al.   INTERNATIONAL JOURNAL OF CANCER

Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention

(2008) Han Kiat Ho et al.   JOURNAL OF HEPATOLOGY

Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer

(2008) Anna Ansell et al.   ORAL ONCOLOGY